Cycloalkyl-hydroxyl compounds and compositions for cholesterol management and related uses
The present invention relates to novel cycloalkyl-hydroxyl compounds, compositions comprising hydroxyl compounds, and methods useful for treating and preventing a variety of diseases and conditions such as, but not limited to aging, Alzheimer's Disease, cancer, cardiovascular disease, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, dyslipidemia, dyslipoproteinemia, hypertension, impotence, inflammation, insulin resistance, lipid elimination in bile, obesity, oxysterol elimination in bile, pancreatitis, Parkinson's disease, a peroxisome proliferator activated receptor-associated disorder, phospholipid elimination in bile, renal disease, septicemia, Syndrome X, thrombotic disorder. Compounds and methods of the invention can also be used to modulate C reactive protein or enhance bile production in a patient. In certain embodiments, the compounds, compositions, and methods of the invention are useful in combination therapy with other therapeutics, such as hypocholesterolemic and hypoglycemic agents.
1. A method for treating or preventing diabetes, diabetic nephropathy, diabetic retinopathy, a disorder of glucose metabolism, or obesity in a patient in need of such treatment or prevention, comprising administering to the patient a therapeutically or prophylactically effective amount of a compound of formula I:
or a pharmaceutically acceptable salt, hydrate, solvate or a mixture thereof, wherein:
(a) each occurrence of m is independently an integer ranging from 0 to 5;
(b) each occurrence of n is independently an integer ranging from 3 to 7;
(c) X is (CH 2 ) z or Ph; wherein z is an integer from 0 to 4;
(d) each occurrence of R 1 and R 2 is independently (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, phenyl, benzyl, or R 1 and R 2 and the carbon to which they are both attached are taken together to form a (C 3 -C 7 )cycloakyl group;
(e) each occurrence of R 11 and R 12 and the carbon to which they are both attached are taken together to form a (C 3 -C 7 )cycloakyl group;
(f) each occurrence of Y 1 and Y 2 is independently (C 1 -C 6 )alkyl, OH, COOH, COOR 3 , SO 3 H,
wherein:
(i) R 3 is (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, (C 2 -C 6 )alkynyl, phenyl, or benzyl and is unsubstituted or substituted with one or more halo, OH, (C 1 -C 6 )alkoxy, or phenyl groups,
(ii) each occurrence of R 4 is independently H, (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl and is unsubstituted or substituted with one or two halo, OH, C 1 -C 6 alkoxy, or phenyl groups; and
(iii) each occurrence of R 5 is independently H, (C 1 -C 6 )alkyl, (C 2 -C 6 )alkenyl, or (C 2 -C 6 )alkynyl.
2. The method compound of claim 1 , wherein each occurrence of Y 1 and Y 2 is independently OH, COOR 3 , or COOH.
3. The method of claim 1 , wherein m is 0.
4. The method of claim 1 , wherein m is 1.
5. The method of claim 1 , wherein n is 4.
6. The method of claim 1 , wherein n is 5.
7. The method of claim 1 , wherein X is (CH 2 ) z and z is 0.
8. The method of claim 1 , wherein each occurrence of R 1 and R 2 and the carbon to which they are both attached are taken together to form a (C 3 -C 7 )cycloakyl group.
9. The method of claim 1 , wherein the compound of formula I is selected from the group consisting of
or a pharmaceutically acceptable salt thereof.
10. The method of claim 1 , wherein the compound of formula I is
or a pharmaceutically acceptable salt thereof.
11. The method of claim 1 , wherein the compound of formula I is
12. The method of claim 1 , wherein the compound of formula I is
or a pharmaceutically acceptable salt thereof.
13. The method of claim 1 , wherein the compound of formula I is
or a pharmaceutically acceptable salt thereof.
14. The method of claim 1 , wherein the compound of formula I is
or a pharmaceutically acceptable salt thereof.
15. The method of claim 1 , wherein the method comprises treating or preventing diabetes.
16. The method of claim 15 , wherein the diabetes is selected from the group consisting non-insulin dependent diabetes mellitus, insulin dependent diabetes mellitus, gestational diabetes mellitus, and maturity onset diabetes of the young.
17. The method of claim 1 , wherein the method comprises treating or preventing diabetic nephropathy or diabetic retinopathy.
18. The method of claim 1 , wherein the method comprises treating or preventing a disorder of glucose metabolism.
19. The method of claim 18 , wherein the disorder of glucose metabolism is selected from the group consisting of impaired glucose tolerance, insulin resistance, high levels of blood insulin, and high levels of blood glucose.
20. The method of claim 1 , wherein the method comprises treating or preventing obesity.